Cite
HARVARD Citation
Tarantini, F. et al. (2022). JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?. Hematology. 27 (1), pp. 842-846. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tarantini, F. et al. (2022). JAK2 V617f in chronic myeloid leukemia: driving force or passive bystander?. Hematology. 27 (1), pp. 842-846. [Online].